T
Takuya Yamashita
Researcher at Osaka University
Publications - 22
Citations - 791
Takuya Yamashita is an academic researcher from Osaka University. The author has contributed to research in topics: Phage display & Breast cancer. The author has an hindex of 14, co-authored 21 publications receiving 704 citations. Previous affiliations of Takuya Yamashita include Teikyo University.
Papers
More filters
Journal ArticleDOI
Carbon Nanotubes Elicit DNA Damage and Inflammatory Response Relative to Their Size and Shape
Kohei Yamashita,Yasuo Yoshioka,Kazuma Higashisaka,Yuki Morishita,Tokuyuki Yoshida,Maho Fujimura,Hiroyuki Kayamuro,Hiromi Nabeshi,Takuya Yamashita,Kazuya Nagano,Yasuhiro Abe,Haruhiko Kamada,Yuichi Kawai,Tadanori Mayumi,Tomoaki Yoshikawa,Norio Itoh,Shin-ichi Tsunoda,Yasuo Tsutsumi +17 more
TL;DR: Comparison of inflammatory responses of various types of CNTs found that peritoneal CNT administration of long and thick MWCNTs increased the total cell number in abdominal lavage fluid in mice, suggesting DNA damage and severe inflammatory effects.
Journal ArticleDOI
Systemic distribution, nuclear entry and cytotoxicity of amorphous nanosilica following topical application
Hiromi Nabeshi,Tomoaki Yoshikawa,Keigo Matsuyama,Yasutaro Nakazato,Kazuhiko Matsuo,Akihiro Arimori,Masaaki Isobe,Saeko Tochigi,Sayuri Kondoh,Toshiro Hirai,Takanori Akase,Takuya Yamashita,Kohei Yamashita,Tokuyuki Yoshida,Kazuya Nagano,Yasuhiro Abe,Yasuo Yoshioka,Haruhiko Kamada,Takayoshi Imazawa,Norio Itoh,Shinsaku Nakagawa,Tadanori Mayumi,Shin-ichi Tsunoda,Yasuo Tsutsumi +23 more
TL;DR: The results suggested that the well-dispersed amorphous nanosilica of particle size 70 nm (nSP70) penetrated the skin barrier and caused systemic exposure in mouse, and induced mutagenic activity in vitro, indicated that further studies of relation between physicochemical properties and biological responses are needed for the development and the safer form of NMs.
Journal ArticleDOI
Carbon Nanomaterials: Efficacy and Safety for Nanomedicine
Takuya Yamashita,Kohei Yamashita,Hiromi Nabeshi,Tomoaki Yoshikawa,Yasuo Yoshioka,Shin-ichi Tsunoda,Yasuo Tsutsumi +6 more
TL;DR: This review discusses currently available information regarding the safety of carbon nanomaterials in nanomedicine applications, including information obtained from the authors' own studies; and it discusses types of carbonnanommaterials that demonstrate particular promise for safe nanomedicsine technologies.
Journal ArticleDOI
Amorphous nanosilicas induce consumptive coagulopathy after systemic exposure
Hiromi Nabeshi,Tomoaki Yoshikawa,Keigo Matsuyama,Yasutaro Nakazato,Akihiro Arimori,Masaaki Isobe,Saeko Tochigi,Sayuri Kondoh,Toshiro Hirai,Takanori Akase,Takuya Yamashita,Kohei Yamashita,Tokuyuki Yoshida,Kazuya Nagano,Yasuhiro Abe,Yasuo Yoshioka,Haruhiko Kamada,Takayoshi Imazawa,Norio Itoh,Masuo Kondoh,Kiyohito Yagi,Tadanori Mayumi,Shin-ichi Tsunoda,Yasuo Tsutsumi +23 more
TL;DR: It is suggested that if interaction between n SP70 and coagulation factors can be suppressed, nSP70-induced harmful effects may be avoided and new frontiers in biological fields by the use of NMs are opened.
Journal ArticleDOI
Therapeutic effect of PEGylated TNFR1-selective antagonistic mutant TNF in experimental autoimmune encephalomyelitis mice
Tetsuya Nomura,Yasuhiro Abe,Haruhiko Kamada,Hiroko Shibata,Hiroyuki Kayamuro,Masaki Inoue,Tomoyuki Kawara,Shuhei Arita,Takeshi Furuya,Takuya Yamashita,Kazuya Nagano,Tomoaki Yoshikawa,Yasuo Yoshioka,Yohei Mukai,Shinsaku Nakagawa,Madoka Taniai,Tsunetaka Ohta,Satoshi Serada,Tetsuji Naka,Shin-ichi Tsunoda,Yasuo Tsutsumi +20 more
TL;DR: Results suggest that selective blocking of TNFR1 by PEG-R1antTNF could be an effective therapeutic strategy against MS.